271 related articles for article (PubMed ID: 24884829)
1. Changes in PKM2 associate with prostate cancer progression.
Wong N; Yan J; Ojo D; De Melo J; Cutz JC; Tang D
Cancer Invest; 2014 Aug; 32(7):330-8. PubMed ID: 24884829
[TBL] [Abstract][Full Text] [Related]
2. [MiR-124 suppresses the proliferation of human prostate cancer PC3 cells by targeting PKM2].
Lü L; Yuan JD; Cao ZL; Huang T; Zhang CH; Wang L; Zeng FQ
Zhonghua Nan Ke Xue; 2014 Jun; 20(6):495-9. PubMed ID: 25029852
[TBL] [Abstract][Full Text] [Related]
3. PKM2 contributes to cancer metabolism.
Wong N; Ojo D; Yan J; Tang D
Cancer Lett; 2015 Jan; 356(2 Pt A):184-91. PubMed ID: 24508027
[TBL] [Abstract][Full Text] [Related]
4. Enhanced expression of the M2 isoform of pyruvate kinase is involved in gastric cancer development by regulating cancer-specific metabolism.
Shiroki T; Yokoyama M; Tanuma N; Maejima R; Tamai K; Yamaguchi K; Oikawa T; Noguchi T; Miura K; Fujiya T; Shima H; Sato I; Murata-Kamiya N; Hatakeyama M; Iijima K; Shimosegawa T; Satoh K
Cancer Sci; 2017 May; 108(5):931-940. PubMed ID: 28235245
[TBL] [Abstract][Full Text] [Related]
5. PKM2 depletion induces the compensation of glutaminolysis through β-catenin/c-Myc pathway in tumor cells.
Wu H; Li Z; Yang P; Zhang L; Fan Y; Li Z
Cell Signal; 2014 Nov; 26(11):2397-405. PubMed ID: 25041845
[TBL] [Abstract][Full Text] [Related]
6. Pyruvate kinase type M2 contributes to the development of pancreatic ductal adenocarcinoma by regulating the production of metabolites and reactive oxygen species.
Yokoyama M; Tanuma N; Shibuya R; Shiroki T; Abue M; Yamamoto K; Miura K; Yamaguchi K; Sato I; Tamai K; Satoh K
Int J Oncol; 2018 Mar; 52(3):881-891. PubMed ID: 29393401
[TBL] [Abstract][Full Text] [Related]
7. Targeting stromal-induced pyruvate kinase M2 nuclear translocation impairs oxphos and prostate cancer metastatic spread.
Giannoni E; Taddei ML; Morandi A; Comito G; Calvani M; Bianchini F; Richichi B; Raugei G; Wong N; Tang D; Chiarugi P
Oncotarget; 2015 Sep; 6(27):24061-74. PubMed ID: 26183399
[TBL] [Abstract][Full Text] [Related]
8. [Silencing pyruvate kinase M2 sensitizes human prostate cancer PC3 cells to gambogic acid-induced apoptosis].
Lü L; Wang L; Jiang GS; Zhang CH; Zeng FQ
Zhonghua Nan Ke Xue; 2013 Feb; 19(2):102-6. PubMed ID: 23441447
[TBL] [Abstract][Full Text] [Related]
9. Rocking cell metabolism: revised functions of the key glycolytic regulator PKM2 in cancer.
Chaneton B; Gottlieb E
Trends Biochem Sci; 2012 Aug; 37(8):309-16. PubMed ID: 22626471
[TBL] [Abstract][Full Text] [Related]
10. Both high expression of pyruvate kinase M2 and vascular endothelial growth factor-C predicts poorer prognosis in human breast cancer.
Lin Y; Liu F; Fan Y; Qian X; Lang R; Gu F; Gu J; Fu L
Int J Clin Exp Pathol; 2015; 8(7):8028-37. PubMed ID: 26339369
[TBL] [Abstract][Full Text] [Related]
11. The multifaceted regulation and functions of PKM2 in tumor progression.
Li Z; Yang P; Li Z
Biochim Biophys Acta; 2014 Dec; 1846(2):285-96. PubMed ID: 25064846
[TBL] [Abstract][Full Text] [Related]
12. Exosome-delivered circRNA promotes glycolysis to induce chemoresistance through the miR-122-PKM2 axis in colorectal cancer.
Wang X; Zhang H; Yang H; Bai M; Ning T; Deng T; Liu R; Fan Q; Zhu K; Li J; Zhan Y; Ying G; Ba Y
Mol Oncol; 2020 Mar; 14(3):539-555. PubMed ID: 31901148
[TBL] [Abstract][Full Text] [Related]
13. The responsively decreased PKM2 facilitates the survival of pancreatic cancer cells in hypoglucose.
Li X; Deng S; Liu M; Jin Y; Zhu S; Deng S; Chen J; He C; Qin Q; Wang C; Zhao G
Cell Death Dis; 2018 Jan; 9(2):133. PubMed ID: 29374159
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of pyruvate kinase M2 associates with aggressive clinicopathological features and unfavorable prognosis in oral squamous cell carcinoma.
Wang Y; Zhang X; Zhang Y; Zhu Y; Yuan C; Qi B; Zhang W; Wang D; Ding X; Wu H; Cheng J
Cancer Biol Ther; 2015; 16(6):839-45. PubMed ID: 25970228
[TBL] [Abstract][Full Text] [Related]
15. RGD-modified oncolytic adenovirus-harboring shPKM2 exhibits a potent cytotoxic effect in pancreatic cancer via autophagy inhibition and apoptosis promotion.
Xu Y; Chu L; Yuan S; Yang Y; Yang Y; Xu B; Zhang K; Liu XY; Wang R; Fang L; Chen Z; Liang Z
Cell Death Dis; 2017 Jun; 8(6):e2835. PubMed ID: 28569774
[TBL] [Abstract][Full Text] [Related]
16. Lack of Evidence for PKM2 Protein Kinase Activity.
Hosios AM; Fiske BP; Gui DY; Vander Heiden MG
Mol Cell; 2015 Sep; 59(5):850-7. PubMed ID: 26300261
[TBL] [Abstract][Full Text] [Related]
17. Activators of PKM2 in cancer metabolism.
Warner SL; Carpenter KJ; Bearss DJ
Future Med Chem; 2014 Jun; 6(10):1167-78. PubMed ID: 25078136
[TBL] [Abstract][Full Text] [Related]
18. PKM2, cancer metabolism, and the road ahead.
Dayton TL; Jacks T; Vander Heiden MG
EMBO Rep; 2016 Dec; 17(12):1721-1730. PubMed ID: 27856534
[TBL] [Abstract][Full Text] [Related]
19. MiR-let-7a inhibits cell proliferation, migration, and invasion by down-regulating PKM2 in gastric cancer.
Tang R; Yang C; Ma X; Wang Y; Luo D; Huang C; Xu Z; Liu P; Yang L
Oncotarget; 2016 Feb; 7(5):5972-84. PubMed ID: 26745603
[TBL] [Abstract][Full Text] [Related]
20. CHIP/Stub1 regulates the Warburg effect by promoting degradation of PKM2 in ovarian carcinoma.
Shang Y; He J; Wang Y; Feng Q; Zhang Y; Guo J; Li J; Li S; Wang Y; Yan G; Ren F; Shi Y; Xu J; Zeps N; Zhai Y; He D; Chang Z
Oncogene; 2017 Jul; 36(29):4191-4200. PubMed ID: 28346425
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
